MedDataX Logo

Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients

NCT ID: NCT00519948

Last Updated: 2008-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare patient comfort and overall lens cleanliness with consecutive use of two multipurpose lens solutions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Comfort Lens Cleanliness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

new MPS, opti-free express no rub MPS

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients 18 yrs or older
2. Males or females
3. Any race or ethnic background
4. CL patients using Opti-Free Express no-rub MPS currently
5. Patients using Focus night and day Lenses

Exclusion Criteria

1. Corneal refractive surgery within 6 months of this study.
2. Corneal ectasia.
3. Current use of Restasis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Innovative Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eyeworks Group

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Chu, OD

Role: PRINCIPAL_INVESTIGATOR

Eyeworks Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eyeworks Group

Fort Worth, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5320

Identifier Type: -

Identifier Source: org_study_id